Literature DB >> 1255208

Genetic associations between myasthenia gravis and the HL-A system.

R Pirskanen.   

Abstract

HL-A antigens were determined in 159 myasthenic patients, 112 of whom were females and 47 males. Fifty-seven patients were thymectomized. The relationship between 23 different HL-A antigens and myasthenia gravis (MG) with reference to sex, age at onset, clinical course of MG, thymus histology, and auxiliary diseases of the patients, as well as the significance of these antigens to 245 relatives of myasthenics, were analysed. The frequencies of HL-A1 and HL-A8 were highly significantly higher in myasthenic patients than in normal Finnish controls. The increase of HL-A1 is secondary and due to a strong linkage disequilibrium between HL-A8 and HL-A1. HL-A8 appeared most often in females with onset of MG before the age of 35 years, and inpatients with thymus hyperplasia. No significant HL-A deviations were found in males or in females with later onset of disease. In seven thymoma patients the occurrence of W10 antigen was almost significantly increased.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255208      PMCID: PMC492209          DOI: 10.1136/jnnp.39.1.23

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  HL-A, immune-response genes, and disease.

Authors:  H O McDevitt; W F Bodmer
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

2.  HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrman; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

3.  HL-A antigens and diabetes mellitus.

Authors:  J Nerup; P Platz; O O Andersen; M Christy; J Lyngsoe; J E Poulsen; L P Ryder; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

4.  Letter: HL-A and idiopathic Addison's disease.

Authors:  P Platz; L Ryder; L S Nielsen; A Svejgaard; M Thomsen; J Nerup; M Christy
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

5.  Letter: Immune response genes in myasthenia gravis.

Authors:  P O Behan; J A Simpson; H Dick
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

6.  HL-A antigen type and small-intestinal disease in dermatitis herpetiformis.

Authors:  R L Gebhard; S I Katz; J Marks; S Shuster; R J Trapani
Journal:  Lancet       Date:  1973-10-06       Impact factor: 79.321

7.  Histocompatibility antigens associated with adult coeliac disease.

Authors:  P L Stokes; P Asquith; G K Holmes; P Mackintosh; W T Cooke
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

8.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

9.  Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle.

Authors:  L I Alpert; A Rule; M Norio; E Kott; P Kornfeld; K E Osserman
Journal:  Am J Clin Pathol       Date:  1972-12       Impact factor: 2.493

10.  The HL-A system. I. Genetics and molecular biology.

Authors:  R Ceppellini; J J van Rood
Journal:  Semin Hematol       Date:  1974-07       Impact factor: 3.851

View more
  11 in total

1.  Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Authors:  Peter K Gregersen; Roman Kosoy; Annette T Lee; Janine Lamb; Jon Sussman; David McKee; Kim R Simpfendorfer; Ritva Pirskanen-Matell; Frederik Piehl; Qiang Pan-Hammarstrom; Jan J G M Verschuuren; Maarten J Titulaer; Erik H Niks; Alexander Marx; Philipp Ströbel; Björn Tackenberg; Michael Pütz; Angelina Maniaol; Ahmed Elsais; Chantal Tallaksen; Hanne F Harbo; Benedicte A Lie; Soumya Raychaudhuri; Paul I W de Bakker; Arthur Melms; Henri-Jean Garchon; Nicholas Willcox; Lennart Hammarstrom; Michael F Seldin
Journal:  Ann Neurol       Date:  2012-10-10       Impact factor: 10.422

2.  Immune disease and HLA associations with myasthenia gravis.

Authors:  P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

3.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  HLA antigens and myasthenia gravis in north India.

Authors:  N K Mehra; G K Ahuja; V Taneja; M C Vaidya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-04       Impact factor: 10.154

5.  Congenital myasthenia gravis: clinical and HLA studies in two brothers.

Authors:  A M Whiteley; M S Schwartz; J A Sachs; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

6.  Immunogenicity of Torpedo acetylcholine receptor in the context of different rat MHC class II haplotypes and non-MHC genomes.

Authors:  Susanne Gaertner; Katrien L de Graaf; Tomas Olsson; Robert Weissert
Journal:  Immunogenetics       Date:  2004-03-05       Impact factor: 2.846

7.  HLA antigens and atopy in children with coeliac disease.

Authors:  M Verkasalo; A Tiilikainen; P Kuitunen; E Savilahti; A Backman
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

Review 8.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

9.  HLA antigens in Japanese patients with myasthenia gravis.

Authors:  K Matsuki; T Juji; K Tokunaga; M Takamizawa; H Maeda; M Soda; Y Nomura; M Segawa
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

10.  Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.

Authors:  Manuela Testi; Chiara Terracciano; Annalisa Guagnano; Giuseppe Testa; Girolama A Marfia; Eugenio Pompeo; Marco Andreani; Roberto Massa
Journal:  Autoimmune Dis       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.